RLYB Rallybio
- 1.700
- +0.050+3.03%
- 1.650
- -0.050-2.94%
Rallybio News
Rallybio Price Target Maintained With a $8.00/Share by JMP Securities
Rallybio Price Target Maintained With a $8.00/Share by JMP Securities
J.P. Morgan Securities: Reiterates the Rallybio (RLYB.US) rating and adjusted from superior to superior market rating, with a target price of $8.00.
J.P. Morgan Securities: Reiterates the Rallybio (RLYB.US) rating and adjusted from superior to superior market rating, with a target price of $8.00.
JMP Securities Reiterates Market Outperform on Rallybio, Maintains $8 Price Target
JMP Securities analyst Jonathan Wolleben reiterates Rallybio (NASDAQ:RLYB) with a Market Outperform and maintains $8 price target.
Rallybio Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/18/2024 346.93% JMP Securities → $8 Reiterates Market Outperform → Market Outperform 04/11/2024 514.53%
Buy Rating Affirmed for Rallybio Amid Significant Market Opportunity in FNAIT Treatment
Rallybio Corporation Announces FNAIT Systematic Literature Review And Meta-Analysis Presented At The Academy Of Managed Care Pharmacy 2024 Annual Meeting
- Data Support HPA-1a Negative Frequency of More than 2% in Nearly 200,000 Screened Pregnant Women -- Among HPA-1a Negative Pregnant Women, Approximately 33% are at Higher Risk for Alloimmunization -R
12 Health Care Stocks Moving In Monday's Intraday Session
GainersLongeveron (NASDAQ:LGVN) stock moved upwards by 44.4% to $2.44 during Monday's regular session. The market value of their outstanding shares is at $7.7 million. Mobile-health Network (NASDAQ:MN
Marinus Pharmaceuticals, Cartesian Therapeutics, Adial Pharmaceuticals Among Healthcare Movers
NXPL, MGRM and OCX Among Pre-market Losers
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of JPMorgan Chase & Co. (NYSE:JPM) fell sharply during Friday's session following first-quarter earnings. Net revenue (managed) of $42.5 billion (+8% Y/Y), beating the consensus of $41.8 billi
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks just under the surface and warrant attention.Investors are constantly o
RallyBio (RLYB) Partners With J&J & Gets $6.6M Funding, Stock Up
Veru, Theravance Biopharma, Adial Pharmaceuticals Among Healthcare Movers
Rallybio Shares Are Trading Lower as the Stock Pulls Back Following Thursday's Surge.
Rallybio Shares Are Trading Lower as the Stock Pulls Back Following Thursday's Surge.
Today's Most Active Stocks: Rallybio, Nikola, Ginkgo Bioworks, and AMD
Top Premarket Decliners
Monogram Orthopaedics (MGRM) shares were down more than 15% in recent Friday premarket activity, paring Thursday's rally. Rallybio Corp. (RLYB) stock was 12% lower, reversing from Thursday's rally. Ad
Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
Shares of NextPlat Corp (NASDAQ:NXPL) rose sharply in today's pre-market trading after the company reported consolidated 2023 revenues of $37.8 million, up 222% year over year NextPlat shares surged
US Equity Markets Close Mixed After March Producer Price Inflation Data
US equity markets closed mixed Thursday following the wholesale producer price inflation data for March. * The US producer price index increased 2.1% year-over-year in March, accelerating from 1.6% in
Sector Update: Health Care Stocks Softer Late Afternoon
Health care stocks were lower late Thursday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both easing around 0.3%. The iShares Biotechnology ETF (IBB) ro
Rallybio RLYB Collaboration JNJ; Aptevo APVO Offering
Analysis
Price Target
No Data
